Teleflex Incorporated

NYSE:TFX

Medical - Instruments & Supplies

Healthcare
$165.85 +0.83%

+$1.04 today

Market cap
$6.58B
Beta
0.82
P/E (TTM)
-5.5
EPS (TTM)
-$22.79
Dividend yield
1.08%
52W Low $100.18High $139.67

Volume 1.16M

Average 0.80M

TFX EPS (Basic)

Net income attributable to common shareholders divided by the weighted average basic shares outstanding.

Teleflex IncorporatedNYSE: TFX

EPS (Basic) · Q2 FY2026 · quarter ended Jun 2026

EPS (Basic) declines year over year

Q2 FY2026 EPS (Basic) of $2.29 fell 17.3% year over year, ahead of the -643.9% change in trailing-twelve-month EPS (Basic).

Context

  • EPS (Basic) increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether EPS (Basic) reaches the consensus estimate from 7 analysts of $7.68 (+137.8%) for the fiscal year ending Dec 2026, a step up from the -1462.4% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
$2.29+1372.2% QoQ
Last fiscal yearDec 2025
-$20.3-1462.4% YoY
LTMJun 2026
-$23.28-643.9% YoY
EPS (Basic) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-17.3%+120.6%+137.9 pp
1 year-1462.4%+137.8%+1600.2 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Basic) history

USD · from the income statement

Latest · FY2025
(20.30) USD
Year-over-year change
-1462.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Basic) vs competitors

How TFX compares with its peers on the latest reported figures

  • Peers report in different currencies, so EPS (Basic) is compared through growth and rates rather than absolute size.
  • Its year-over-year change of -643.9% is the 10th highest of 11, against a peer median of -39.9%.
TFX Competitors
EPS (Basic) for TFX and competitors
Company Period LTM YoY 3-year CAGR
KRYSKrystal Biotech, Inc.LTM Jun 2026$8.27 USD+62.2%—
MMSIMerit Medical Systems, Inc.LTM Sep 2026$2.69 USD+33.8%+18.3%
TGTXTG Therapeutics, Inc.LTM Sep 2026$0.74 USD-75.8%—
STVNStevanato Group S.p.A.LTM Jun 2026€0.48 EUR-4.0%-2.6%
ALKSAlkermes plcLTM Sep 2026$0 USD-99.9%—
BLCOBausch + Lomb CorporationLTM Jun 2026-$0.48 USD+38.5%—
PTCTPTC Therapeutics, Inc.LTM Jun 2026-$0.49 USD-106.1%—
CRSPCRISPR Therapeutics AGLTM Sep 2026-$4.74 USD+15.2%—
ARWRArrowhead Pharmaceuticals, Inc.LTM Sep 2026-$5.09 USD-12629.9%—
PCVXVaxcyte, Inc.LTM Jun 2026-$7.64 USD-81.5%—
TFXTeleflex IncorporatedLTM Jun 2026-$23.28 USD-643.9%—
Peer median (excluding TFX) —-39.9%+7.9%

Competitors are the stored peer set for TFX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue2.81B2.79B2.97B3.05B1.99B
Cost of Revenue1.26B1.26B1.33B1.34B871.96M
Gross Profit1.55B1.53B1.65B1.7B1.12B
Gross Margin55.2%54.9%55.4%55.9%56.2%
Research & Development130.84M153.82M154.35M161.67M144.78M
Selling, General & Admin860.09M863.75M929.87M995.27M720.17M
Operating Expenses921.51M1.03B1.14B1.55B864.95M
Depreciation & Amortization237.36M230.59M242.12M274.6M177.74M
EBITDA853.8M730.77M761.21M433.62M302.51M
EBITDA Margin30.4%26.2%25.6%14.2%15.2%
Operating Income628.1M499.73M506.31M151.01M255.8M
Operating Margin22.4%17.9%17.0%5.0%12.8%
Interest Income1.33M912K12.78M8.01M6.4M
Interest Expense56.97M54.26M85.08M83.54M100.22M
Other Income / Expenses(68.63M)(53.81M)(72.3M)(75.54M)(231.25M)
Income Before Tax559.47M445.92M434.01M75.48M24.55M
Pre-Tax Margin19.9%16.0%14.6%2.5%1.2%
Income Tax Expense74.35M83M76.44M5.32M(33.98M)
Net Income485.37M363.14M356.33M69.68M(905.64M)
Net Margin17.3%13.0%12.0%2.3%-45.4%
EPS (Basic)10.387.747.581.49(20.30)
EPS (Diluted)10.237.687.531.48(20.25)
Weighted Avg Shares46.77M46.9M46.98M46.84M44.62M
Weighted Avg Shares (Diluted)47.43M47.31M47.3M47.09M44.72M

Teleflex Incorporated

NYSE:TFX

Intrinsic Alpha fair value

Locked

Current Price

$165.85

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.